{"id":12359,"date":"2025-03-20T14:46:07","date_gmt":"2025-03-20T14:46:07","guid":{"rendered":"https:\/\/www.healthnews.ie\/?p=12359"},"modified":"2025-03-24T09:16:42","modified_gmt":"2025-03-24T09:16:42","slug":"process-design-solution-company-facilitates-complex-pharmaceutical-production","status":"publish","type":"post","link":"https:\/\/www.healthnews.ie\/clinical-trials\/process-design-solution-company-facilitates-complex-pharmaceutical-production\/","title":{"rendered":"Process design solution company facilitates complex pharmaceutical production"},"content":{"rendered":"\n<div style=\"background-color:#f2f2f2;color:#32373c\" class=\"wp-block-atomic-blocks-ab-profile-box round ab-has-avatar ab-font-size-14 ab-block-profile ab-profile-columns\"><div class=\"ab-profile-column ab-profile-avatar-wrap\"><div class=\"ab-profile-image-wrap\"><figure class=\"ab-profile-image-square\"><img loading=\"lazy\" decoding=\"async\" width=\"505\" height=\"504\" class=\"ab-profile-avatar wp-image-12360\" src=\"https:\/\/s3.eu-north-1.amazonaws.com\/cdn-site.mediaplanet.com\/app\/uploads\/sites\/94\/2025\/03\/20143924\/vicky-1742481564-Aine-Headshot.jpg\" alt=\"\" srcset=\"https:\/\/s3.eu-north-1.amazonaws.com\/cdn-site.mediaplanet.com\/app\/uploads\/sites\/94\/2025\/03\/20143924\/vicky-1742481564-Aine-Headshot.jpg 505w, https:\/\/s3.eu-north-1.amazonaws.com\/cdn-site.mediaplanet.com\/app\/uploads\/sites\/94\/2025\/03\/20143924\/vicky-1742481564-Aine-Headshot-125x125.jpg 125w\" sizes=\"auto, (max-width: 505px) 100vw, 505px\" \/><\/figure><\/div><\/div><div class=\"ab-profile-column ab-profile-content-wrap\"><h2 class=\"ab-profile-name\" style=\"color:#32373c\">Aine Dunne<\/h2><p class=\"ab-profile-title\" style=\"color:#32373c\">Chief Executive Officer, Process Facilities Group International (PFGi)<\/p><div class=\"ab-profile-text\"><\/div><ul class=\"ab-social-links\"><\/ul><\/div><\/div>\n\n\n\n<p><em>Engineering consultancy supports the transition from initial research to large-scale manufacturing, delivering high-quality, safe and efficient design solutions.<\/em><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p>In medical research and pharmaceutical development, the transition from early-stage research to large-scale manufacturing is a key aspect of ensuring equitable access to innovative treatments.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-scaling-up-pharmaceutical-manufacturing\"><strong>Scaling up pharmaceutical manufacturing<\/strong><\/h2>\n\n\n\n<p>While medical innovation and clinical trial evidence lay the groundwork for developing new therapeutic approaches, scaling up production while maintaining safety, efficacy and regulatory compliance can be challenging.<\/p>\n\n\n\n<p>\u201cThe scale-up process is as important as it is complex, and the transition to industrial manufacturing requires extensive input,\u201d explains Aine Dunne, Chief Executive Officer of <a href=\"https:\/\/www.linkedin.com\/company\/process-facilities-group-international\/\" target=\"_blank\" rel=\"noreferrer noopener\">Process Facilities Group International <\/a>(PFGi). \u201cOur team, with backgrounds in research, development and scale-up, work closely with pharmaceutical and life science companies to streamline this process.\u201d<\/p>\n\n\n<div id=\"healt-380048957\"><div class=\"healt-adlabel\">Advertisements<\/div><div id=\"healt-575028784\" style=\"margin-top: 30px;margin-bottom: 30px;\"><a data-no-instant=\"1\" href=\"https:\/\/www.linkedin.com\/company\/process-facilities-group-international\/\" rel=\"noopener\" class=\"a2t-link\" target=\"_blank\" aria-label=\"vicky-1742482307-PFGI desk\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/s3.eu-north-1.amazonaws.com\/cdn-site.mediaplanet.com\/app\/uploads\/sites\/94\/2025\/03\/20145148\/vicky-1742482307-PFGI-desk.jpg\" alt=\"\"  width=\"750\" height=\"250\"   \/><\/a><\/div><\/div>\n\n\n<h2 class=\"wp-block-heading\" id=\"h-tailored-engineering-solutions\"><strong>Tailored engineering solutions<\/strong><strong><\/strong><\/h2>\n\n\n\n<p>PFGi is an engineering consultancy specialising in design solutions for complex processes. They help to facilitate the transition from initial research to large-scale manufacturing, supporting pharmaceutical companies, contract research organisations and biotech firms to scale up their production.<\/p>\n\n\n\n<p>\u201cWe don\u2019t just size equipment; we collaborate with companies to develop entirely new processes or integrate innovations into existing facilities,\u201d says Dunne. \u201cWe don\u2019t expect a fully developed process. Our hands-on approach ensures that companies can adapt to the evolving demands of the industry while maintaining efficiency and regulatory compliance.\u201d<\/p>\n\n\n\n<p>With key services such as equipment selection, process mapping and batch manufacturing, the company actively engages in the developmental process, working alongside clients to refine and optimise their production procedures.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>As the industry adapts to develop <br>more niche and high-cost biotech <br>drugs, manufacturing is key.<\/p>\n<\/blockquote>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-global-pharma-manufacturing-solutions\"><strong>Global pharma manufacturing solutions<\/strong><\/h2>\n\n\n\n<p>Working with life science companies globally to commercialise their manufacturing processes, PFGi has offices in Ireland, Eastern Europe, China, India, North America and South America. \u201cWe have worked with a number of companies in the US, commercialising their small-scale laboratory process to reach a wider market,\u201d explains Dunne. \u201cAs the industry adapts to develop more niche and high-cost biotech drugs, manufacturing is key. We help companies reduce costs and bring drugs to market faster, minimising capital outlay and providing expert guidance throughout each stage of the process.\u201d<\/p>\n\n\n\n<p>She adds: \u201cSustainability is a core aspect of engineering in commercial pharma, and our CRP [critical resource planning] and SRP [sustainable resource planning] experts can design efficient systems that minimise water usage, ensure energy systems are appropriately sized and consult on the use of alternative energy sources.\u201d<\/p>\n\n\n\n<p>The company prioritises high-quality, safe and efficient design solutions while building lasting, trust-based relationships for successful project outcomes.<\/p>\n\n\n\n<div style=\"color:#32373c;background-color:#005581\" class=\"wp-block-atomic-blocks-ab-notice ab-font-size-18 ab-block-notice\" data-id=\"5e5432\"><div class=\"ab-notice-text\" style=\"border-color:#005581\"><p>To find out more: <a href=\"https:\/\/www.processfgi.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/www.processfgi.com\/<\/a><\/p><\/div><\/div>\n\n\n\n<p><a id=\"_msocom_1\"><\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Engineering consultancy supports the transition from initial research to large-scale manufacturing, delivering high-quality, safe and efficient design solutions. In medical research and pharmaceutical development, the transition from early-stage research to large-scale manufacturing is a key aspect of ensuring equitable access to innovative treatments. Scaling up pharmaceutical manufacturing While medical innovation and clinical trial evidence lay &hellip; <a href=\"https:\/\/www.healthnews.ie\/clinical-trials\/process-design-solution-company-facilitates-complex-pharmaceutical-production\/\">Continued<\/a><\/p>\n","protected":false},"author":91,"featured_media":12362,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5829],"tags":[5960],"class_list":["post-12359","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-clinical-trials","tag-clinical-trials-2025"],"acf":[],"featured_image_src":"https:\/\/s3.eu-north-1.amazonaws.com\/cdn-site.mediaplanet.com\/app\/uploads\/sites\/94\/2025\/03\/20144351\/vicky-1742481830-AdobeStock_661151862-600x400.jpg","featured_image_src_square":"https:\/\/s3.eu-north-1.amazonaws.com\/cdn-site.mediaplanet.com\/app\/uploads\/sites\/94\/2025\/03\/20144351\/vicky-1742481830-AdobeStock_661151862-600x600.jpg","author_info":{"display_name":"henryphillips","author_link":"https:\/\/www.healthnews.ie\/author\/henryphillips\/"},"vicky_category_order":[{"category_id":5829,"order":"7"}],"vicky_index_order":"15","_links":{"self":[{"href":"https:\/\/www.healthnews.ie\/wp-json\/wp\/v2\/posts\/12359","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthnews.ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthnews.ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthnews.ie\/wp-json\/wp\/v2\/users\/91"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthnews.ie\/wp-json\/wp\/v2\/comments?post=12359"}],"version-history":[{"count":3,"href":"https:\/\/www.healthnews.ie\/wp-json\/wp\/v2\/posts\/12359\/revisions"}],"predecessor-version":[{"id":12423,"href":"https:\/\/www.healthnews.ie\/wp-json\/wp\/v2\/posts\/12359\/revisions\/12423"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.healthnews.ie\/wp-json\/wp\/v2\/media\/12362"}],"wp:attachment":[{"href":"https:\/\/www.healthnews.ie\/wp-json\/wp\/v2\/media?parent=12359"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthnews.ie\/wp-json\/wp\/v2\/categories?post=12359"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthnews.ie\/wp-json\/wp\/v2\/tags?post=12359"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}